Advertisement

Pediatric Cardiology

, Volume 32, Issue 3, pp 360–365 | Cite as

Molecular Genetics and Pathogenesis of Arrhythmogenic Right Ventricular Cardiomyopathy: A Disease of Cardiac Stem Cells

  • Raffaella Lombardi
  • A. J. MarianEmail author
Riley Symposium

Abstract

Arrhythmogenic right ventricular cardiomyopathy (ARVC) is an uncommon cardiomyopathy characterized by fibroadiposis replacing cardiac myocytes, predominantly in the right ventricle. The clinical phenotype is characterized by cardiac arrhythmias, sudden cardiac death, and heart failure. The molecular genetic basis of ARVC is partially known. Mutations in DSP (desmoplakin), JUP (plakoglobin), PKP2 (plakophilin 2), DSG2 (desmoglein 2), and DSC2 (desmocollin 2) are responsible for approximately half of the cases. Mutations in TMEM43 and TGFB3, encoding transmembrane protein 43 and transforming growth factor β3, respectively, also have been associated with ARVC. The molecular pathogenesis of ARVC has at least two components. The first component is fibroadiposis, which is the characteristics hallmark of the disease. The second is cardiac dysfunction, which is primarily due to impaired myocyte-to-myocyte attachment. The pathogenesis of fibroadiposis involves partial nuclear translocation of plakoglobin (PG) and subsequent suppression of canonical Wnt signaling, which is involved in the development of the right ventricle and its outflow tract, the predominant sites of involvement in ARVC. Suppression of the canonical Wnt signaling results in a switch to adipogenesis in the second heart field progenitor cells. Accordingly, ARVC is a disease of cardiac progenitor cells that have gone awry and differentiated to adipocytes.

Keywords

Adipogenesis Cardiomyopathy Desmosome Genetics Mutation Wnt signaling 

References

  1. 1.
    Ai D, Fu X, Wang J et al (2007) Canonical Wnt signaling functions in second heart field to promote right ventricular growth. Proc Natl Acad Sci USA 104:9319–9324PubMedCrossRefGoogle Scholar
  2. 2.
    Alcalai R, Metzger S, Rosenheck S et al (2003) A recessive mutation in desmoplakin causes arrhythmogenic right ventricular dysplasia, skin disorder, and woolly hair. J Am Coll Cardiol 42:319–327PubMedCrossRefGoogle Scholar
  3. 3.
    Beffagna G, De Bortoli M, Nava A et al (2007) Missense mutations in desmocollin-2 N-terminus, associated with arrhythmogenic right ventricular cardiomyopathy, affect intracellular localization of desmocollin-2 in vitro. BMC Med Genet 8:65PubMedCrossRefGoogle Scholar
  4. 4.
    Beffagna G, Occhi G, Nava A et al (2005) Regulatory mutations in transforming growth factor-beta3 gene cause arrhythmogenic right ventricular cardiomyopathy type 1. Cardiovasc Res 65:366–373PubMedCrossRefGoogle Scholar
  5. 5.
    Carvajal-Huerta L (1998) Epidermolytic palmoplantar keratoderma with woolly hair and dilated cardiomyopathy. J Am Acad Dermatol 39:418–421PubMedCrossRefGoogle Scholar
  6. 6.
    Corrado D, Thiene G, Nava A et al (1990) Sudden death in young competitive athletes: clinicopathologic correlations in 22 cases. Am J Med 89:588–596PubMedCrossRefGoogle Scholar
  7. 7.
    Delmar M, McKenna WJ (2010) The cardiac desmosome and arrhythmogenic cardiomyopathies: from gene to disease. Circ Res 107:700–714PubMedCrossRefGoogle Scholar
  8. 8.
    Fressart V, Duthoit G, Donal E et al (2010) Desmosomal gene analysis in arrhythmogenic right ventricular dysplasia/cardiomyopathy: spectrum of mutations and clinical impact in practice. Europace 12:861–868PubMedCrossRefGoogle Scholar
  9. 9.
    Garcia-Gras E, Lombardi R, Giocondo MJ et al (2006) Suppression of canonical Wnt/beta-catenin signaling by nuclear plakoglobin recapitulates phenotype of arrhythmogenic right ventricular cardiomyopathy. J Clin Invest 116:2012–2021PubMedCrossRefGoogle Scholar
  10. 10.
    Gerull B, Heuser A, Wichter T et al (2004) Mutations in the desmosomal protein plakophilin-2 are common in arrhythmogenic right ventricular cardiomyopathy. Nat Genet 36:1162–1164PubMedCrossRefGoogle Scholar
  11. 11.
    Heuser A, Plovie ER, Ellinor PT et al (2006) Mutant desmocollin-2 causes arrhythmogenic right ventricular cardiomyopathy. Am J Hum Genet 79:1081–1088PubMedCrossRefGoogle Scholar
  12. 12.
    Lombardi R, Dong J, Rodriguez G et al (2009) Genetic fate mapping identifies second heart field progenitor cells as a source of adipocytes in arrhythmogenic right ventricular cardiomyopathy. Circ Res 104:1076–1084PubMedCrossRefGoogle Scholar
  13. 13.
    Maron BJ, Shirani J, Poliac LC et al (1996) Sudden death in young competitive athletes: clinical, demographic, and pathological profiles. JAMA 276:199–204PubMedCrossRefGoogle Scholar
  14. 14.
    McKoy G, Protonotarios N, Crosby A et al (2000) Identification of a deletion in plakoglobin in arrhythmogenic right ventricular cardiomyopathy with palmoplantar keratoderma and woolly hair (Naxos disease). Lancet 355:2119–2124PubMedCrossRefGoogle Scholar
  15. 15.
    Merner ND, Hodgkinson KA, Haywood AFM et al (2008) Arrhythmogenic right ventricular cardiomyopathy type 5 is a fully penetrant, lethal arrhythmic disorder caused by a missense mutation in the TMEM43 gene. Am J Hum Genet 82:809–821PubMedCrossRefGoogle Scholar
  16. 16.
    Norgett EE, Hatsell SJ, Carvajal-Huerta L et al (2000) Recessive mutation in desmoplakin disrupts desmoplakin-intermediate filament interactions and causes dilated cardiomyopathy, woolly hair, and keratoderma. Hum Mol Genet 9:2761–2766PubMedCrossRefGoogle Scholar
  17. 17.
    Norman M, Simpson M, Mogensen J et al (2005) Novel mutation in desmoplakin causes arrhythmogenic left ventricular cardiomyopathy. Circulation 112:636–642PubMedCrossRefGoogle Scholar
  18. 18.
    Pilichou K, Nava A, Basso C et al (2006) Mutations in desmoglein-2 gene are associated with arrhythmogenic right ventricular cardiomyopathy. Circulation 113:1171–1179PubMedCrossRefGoogle Scholar
  19. 19.
    Priori SG, Napolitano C, Tiso N et al (2001) Mutations in the cardiac ryanodine receptor gene (hRyR2) underlie catecholaminergic polymorphic ventricular tachycardia. Circulation 103:196–200PubMedGoogle Scholar
  20. 20.
    Ross SE, Hemati N, Longo KA et al (2000) Inhibition of adipogenesis by Wnt signaling. Science 289:950–953PubMedCrossRefGoogle Scholar
  21. 21.
    Sen-Chowdhry S, Syrris P, Prasad SK et al (2008) Left-dominant arrhythmogenic cardiomyopathy: an under-recognized clinical entity. J Am Coll Cardiol 52:2175–2187PubMedCrossRefGoogle Scholar
  22. 22.
    Shen WK, Edwards WD, Hammill SC et al (1995) Sudden unexpected nontraumatic death in 54 young adults: a 30-year population-based study. Am J Cardiol 76:148–152PubMedCrossRefGoogle Scholar
  23. 23.
    Simpson MA, Mansour S, Ahnood D et al (2009) Homozygous mutation of desmocollin-2 in arrhythmogenic right ventricular cardiomyopathy with mild palmoplantar keratoderma and woolly hair. Cardiology 113:28–34PubMedCrossRefGoogle Scholar
  24. 24.
    Syrris P, Ward D, Evans A et al (2006) Arrhythmogenic right ventricular dysplasia/cardiomyopathy associated with mutations in the desmosomal gene desmocollin-2. Am J Hum Genet 79:978–984PubMedCrossRefGoogle Scholar
  25. 25.
    Tabib A, Loire R, Chalabreysse L et al (2003) Circumstances of death and gross and microscopic observations in a series of 200 cases of sudden death associated with arrhythmogenic right ventricular cardiomyopathy and/or dysplasia. Circulation 108:3000–3005PubMedCrossRefGoogle Scholar
  26. 26.
    Thiene G, Nava A, Corrado D et al (1988) Right ventricular cardiomyopathy and sudden death in young people. N Engl J Med 318:129–133PubMedCrossRefGoogle Scholar
  27. 27.
    Tiso N, Stephan DA, Nava A et al (2001) Identification of mutations in the cardiac ryanodine receptor gene in families affected with arrhythmogenic right ventricular cardiomyopathy type 2 (ARVD2). Hum Mol Genet 10:189–194PubMedCrossRefGoogle Scholar
  28. 28.
    van Tintelen JP, Entius MM, Bhuiyan ZA et al (2006) Plakophilin-2 mutations are the major determinant of familial arrhythmogenic right ventricular dysplasia/cardiomyopathy. Circulation 113:1650–1658PubMedCrossRefGoogle Scholar

Copyright information

© Springer Science+Business Media, LLC 2011

Authors and Affiliations

  1. 1.Center for Cardiovascular Genetics, Institute of Molecular Medicine and Department of MedicineUniversity of Texas Health Sciences Center at Houston, Texas Heart Institute at St. Luke’s Epsicopal HospitalHoustonUSA

Personalised recommendations